Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1375929
PUBLISHER: Grand View Research | PRODUCT CODE: 1375929
North America Veterinary Oncology Market Size, Share & Trends Analysis Report By Animal Type (Canine, Feline), By Therapy (Radiotherapy, Surgery), By Cancer Type, By Country, And Segment Forecasts, 2023 - 2033
PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
North America Veterinary Oncology Market Growth & Trends:
The North America veterinary oncology market size is expected to reach USD 1.46 billion by 2033, according to a new report by Grand View Research, Inc.. The market is projected to grow at a CAGR of 10.57% from 2023 to 2033. The market is driven by the rising incidence of cancer in pets, the number of veterinary clinical trials investigating the safety and effectiveness of various oncologic therapies, and the increasing penetration of pet insurance. Moreover, increasing strategic initiatives for R&D of targeted therapies for cancer in companion animals is boosting market growth. For instance, in July 2023, Ardent Animal Health partnered with FidoCure to expand access to oncology innovation in veterinary medicine by leveraging the latter's genomic testing and precision medicine platform.
During COVID-19, the market witnessed dampened growth owing to several challenges. The pandemic impacted veterinary cancer research & development efforts and the logistics supply of crucial pet pharmaceuticals. It also limited access to veterinary care. According to the Global Animal Health Association's 2020 report, pet owners in a study said that in many countries, veterinarian services were hampered by delayed or skipped care for pets. The pandemic, however, also accelerated the adoption of digital technologies to enhance care. In March 2020, PetCure Oncology upgraded its Telehealth options to enable pet families and referring veterinarians to remotely connect with its board-certified radiation oncologists.
The market is fragmented and competitive due to the presence of several small-to-large market players. Players are actively involved in deploying strategic initiatives to gain market share. For instance, in January 2022, Dechra acquired the rights to sell, market, and support Laverdia-CA1 (verdinexor tablets) in the U.S. from Anivive Lifesciences, Inc. In June 2022, Boehringer Ingelheim International GmbH entered into a research partnership with CarthroniX, a biopharma company, to develop small molecule therapeutics in canine oncology. In April 2023, Torigen Pharmaceuticals partnered with Veterinary Management Groups (VMG) to provide their experimental autologous prescription products and services to the latter's more than 2,000 member clinics network.
North America Veterinary Oncology Market Report Highlights:
- Based on animal type, the canine segment dominated the market in 2022 with a revenue share of over 85%. The feline segment, on the other hand, is projected to grow at the fastest CAGR of over 12% over the forecast period. This is attributed to the increasing partnerships and collaborations to further the development and launch of reliable veterinary cancer therapies. In October 2022, Ardent Animal Health, for example, completed a license agreement for a novel checkpoint inhibitor for canine cancer treatment
- In terms of therapy, the surgery segment dominated the market in 2022 with a revenue share of over 35%. The immunotherapy segment is projected to grow at the fastest CAGR of 12% over the forecast period
- Based on cancer type, the skin cancers segment dominated the market in 2022 with a revenue share of over 38%. The others segment is projected to grow at the fastest CAGR of over 11% over the forecast period
- Based on country, the U.S. held the largest revenue share in the market in 2022, while Canada is anticipated to grow at a CAGR of over 13% over the forecast period. The growth in the U.S. is attributed to the presence of key players and strategic initiatives by market players. In April 2023, Torigen Pharmaceuticals opened a new production facility and headquarters in Farmington, Connecticut, U.S.
Product Code: GVR-4-68040-138-7
Table of Contents
Chapter 1 Methodology And Scope
- 1.1 Market Segmentation And Scope
- 1.1.1 Report Scope & Assumptions
- 1.1.2 Country Scope And Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database
- 1.3.2 Gvr's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.4 Information/Data Analysis
- 1.4.1 Information Analysis
- 1.5 Market Formulation & Visualization
- 1.6 Data Validation & Publishing
- 1.7 Model Details
- 1.7.1 Approach 1: Volume X Price Analysis
- 1.7.1.1 Bottom-Up Market Estimation
- 1.7.1.2 Top-Down Market Estimation
- 1.7.2 Approach 2: Commodity Flow Analysis
- 1.7.3 Global Market: Cagr Calculation
- 1.7.1 Approach 1: Volume X Price Analysis
- 1.8 List Of Secondary Sources
Chapter 2 Executive Summary
- 2.1 Market Snapshot
- 2.2 Animal Type & Therapy Segment Snapshot
- 2.3 Cancer Type Segment Snapshot
- 2.4 Competitive Landscape Snapshot
Chapter 3 North America Veterinary Oncology Market Industry Outlook
- 3.1 Market Lineage Outlook
- 3.1.1 Parent Market Analysis
- 3.1.2 Ancillary Market Analysis
- 3.2 North America Veterinary Oncology Market Dynamics
- 3.2.1 Market Driver Impact Analysis
- 3.2.1.1 Increasing Prevalence Of Cancer In Pets
- 3.2.1.2 Increasing R&D In Pet Cancer Therapy
- 3.2.1.3 Growing Focus On Animal Safety
- 3.2.1.4 Growing Uptake Of Pet Insurance
- 3.2.1.5 Technological Advancements In Pet Cancer Treatment
- 3.2.1.6 Increase In Pet Population
- 3.2.2 Market Restraint Impact Analysis
- 3.2.2.1 High Cost Of Treatment
- 3.2.2.2 Adverse Effects Associated With Therapies
- 3.2.2.3 Limited Clinical Evidence
- 3.2.3 Market Opportunity Analysis
- 3.2.4 Market Challenge Analysis
- 3.2.1 Market Driver Impact Analysis
- 3.3 North America Veterinary Oncology Market: Porter's 5 Forces Analysis
- 3.3.1 Bargaining Power Of Buyers
- 3.3.2 Bargaining Power Of Suppliers
- 3.3.3 Threat Of New Entrants
- 3.3.4 Threat Of Substitutes
- 3.3.5 Competitive Rivalry
- 3.4 North America Veterinary Oncology Market: Pestel Analysis
- 3.4.1 Political & Legal Landscape
- 3.4.2 Economic Landscape
- 3.4.3 Technological Landscape
- 3.4.4 Social Landscape
- 3.4.5 Environmental Landscape
- 3.5 Regulatory Landscape
- 3.6 Reimbursement Landscape
- 3.7 Covid-19 Impact Analysis
- 3.8 User Perspective Analysis
- 3.9 Estimated Number Of Veterinary Service Establishments In The U.S., 2018 To 2030
- 3.10 Estimated Animal Population By Species And By Country, 2022
- 3.11 Estimated Average Cost Of Cancer Treatment
- 3.12 Estimated Number Of Tumor Removal Procedures
- 3.13 Estimated Number Of Certified Veterinary Oncologists
Chapter 4 Animal Type Estimates & Trend Analysis, 2018 - 2033 (USD Million)
- 4.1 North America Veterinary Oncology Market By Animal Type: Key Takeaways
- 4.2 Animal Type Movement Analysis & Market Share, 2022 & 2033
- 4.3 North America Veterinary Oncology Market Estimates & Forecast, By Animal Type (USD Million)
- 4.4 Canine
- 4.4.1 Canine Market Estimates And Forecasts, 2018 - 2033 (USD Million)
- 4.5 Feline
- 4.5.1 Feline Market Estimates And Forecasts, 2018 - 2033 (USD Million)
- 4.6 Equine
- 4.6.1 Equine Market Estimates And Forecasts, 2018 - 2033 (USD Million)
Chapter 5 Therapy Estimates & Trend Analysis, 2018 - 2033 (USD Million)
- 5.1 North America Veterinary Oncology Market By Therapy: Key Takeaways
- 5.2 Therapy Movement Analysis & Market Share, 2022 & 2033
- 5.3 North America Veterinary Oncology Market Estimates & Forecast, By Therapy (USD Million)
- 5.3.1. North America radiotherapy Market, By Type, 2018 - 2033 (USD Million)
- 5.3.1.1. North America Stereotactic Radiation Therapy Market, By Type, 2018 - 2033 (USD Million)
- 5.3.1. North America radiotherapy Market, By Type, 2018 - 2033 (USD Million)
- 5.4 Radiotherapy
- 5.4.1 Radiotherapy Market Estimates And Forecasts, 2018 - 2033 (USD Million)
- 5.4.2 Stereotactic Radiation Therapy
- 5.4.2.1 Stereotactic Radiation Therapy Market Estimates And Forecasts, 2018 - 2033 (USD Million)
- 5.4.2.2 Linac
- 5.4.2.2.1 Linac Market Estimates And Forecasts, 2018 - 2033 (USD Million)
- 5.4.2.3 Others
- 5.4.2.3.1 Others Market Estimates And Forecasts, 2018 - 2033 (USD Million)
- 5.4.3 Conventional Radiation Therapy
- 5.4.3.1 Conventional Radiation Therapy Market Estimates And Forecasts, 2018 - 2033 (USD Million)
- 5.5 Surgery
- 5.5.1 Surgery Market Estimates And Forecasts, 2018 - 2033 (USD Million)
- 5.6 Chemotherapy
- 5.6.1 Chemotherapy Market Estimates And Forecasts, 2018 - 2033 (USD Million)
- 5.7 Immunotherapy
- 5.7.1 Immunotherapy Market Estimates And Forecasts, 2018 - 2033 (USD Million)
- 5.8 Other Therapies
- 5.8.1 Other Therapies Market Estimates And Forecasts, 2018 - 2033 (USD Million)
Chapter 6 Cancer Type Estimates & Trend Analysis, 2018 - 2033 (USD Million)
- 6.1 North America Veterinary Oncology Market By Cancer Type: Key Takeaways
- 6.2 Cancer Type Movement Analysis & Market Share, 2022 & 2033
- 6.3 North America Veterinary Oncology Market Estimates & Forecast, By Cancer Type (USD Million)
- 6.4 Skin Cancers
- 6.4.1 Skin Cancers Market Estimates And Forecasts, 2018 - 2033 (USD Million)
- 6.5 Lymphomas
- 6.5.1 Lymphomas Market Estimates And Forecasts, 2018 - 2033 (USD Million)
- 6.6 Sarcomas
- 6.6.1 Sarcomas Market Estimates And Forecasts, 2018 - 2033 (USD Million)
- 6.7 Others
- 6.7.1 Others Market Estimates And Forecasts, 2018 - 2033 (USD Million)
Chapter 7 Regional Estimates & Trend Analysis, 2018 - 2033 (USD Million)
- 7.1 Regional Outlook
- 7.2 North America
- 7.2.1 North America Veterinary Oncology Market Estimates And Forecasts, 2018 - 2033 (USD Million)
- 7.2.2 U.S.
- 7.2.2.1 U.S. Veterinary Oncology Market Estimates And Forecasts, 2018 - 2033 (USD Million)
- 7.2.3 Canada
- 7.2.3.1 Canada Veterinary Oncology Market Estimates And Forecasts, 2018 - 2033 (USD Million)
Chapter 8 Competitive Landscape
- 8.1 Market Participant Categorization
- 8.2 Company Market Position Analysis, 2022, (Heat Map Analysis)
- 8.3 Market Leaders & Innovators
- 8.4 Key Company Profiles
- 8.4.1 Participants Overview
- 8.4.2 Financial Performance
- 8.4.3 Therapy Benchmarking
- 8.4.4 Strategic Initiatives
- 8.4.4.1 Boehringer Ingelheim International Gmbh
- 8.4.4.2 Elanco Animal Health
- 8.4.4.3 Zoetis Services Llc
- 8.4.4.4 Elekta Ab
- 8.4.4.5 Petcure Oncology
- 8.4.4.6 Accuray Incorporated
- 8.4.4.7 Varian Medical Systems, Inc. (Parent Company: Siemens Healthineers)
- 8.4.4.8 Virbac
- 8.4.4.9 Torigen Pharmaceuticals Inc.
- 8.4.4.10 Dechra Pharmaceuticals Plc
- 8.4.4.11 Novavive Inc.
- 8.4.4.12 Ardent Animal Health, Llc (A Breakthru Company)
- 8.5 Strategy Mapping
- 8.5.1 Approvals & Clearances
- 8.5.2 Mergers & Acquisitions
- 8.5.3 Partnerships & Collaborations
- 8.5.4 Product/ Service Launches/Expansions
- 8.5.5 R&D Partnerships
- 8.5.6 Others
- 8.6 List Of Other Key Market Players
Product Code: GVR-4-68040-138-7
List of Tables
- Table 1 List of secondary sources
- Table 2 North America Veterinary Oncology market, by Country, 2018 - 2033 (USD Million)
- Table 3 North America Veterinary Oncology market, by Animal Type, 2018 - 2033 (USD Million)
- Table 4 North America Veterinary Oncology market, by Therapy, 2018 - 2033 (USD Million)
- Table 5 North America Radiotherapy Market, by Type, 2018 - 2033 (USD Million)
- Table 6 North America Stereotactic Radiation Therapy Market, by Type, 2018 - 2033 (USD Million)
- Table 7 North America Veterinary Oncology Market, by Cancer Type, 2018 - 2033 (USD Million)
- Table 8 US Veterinary Oncology market, by Animal Type, 2018 - 2033 (USD Million)
- Table 9 US Veterinary Oncology market, by Therapy, 2018 - 2033 (USD Million)
- Table 10 US Radiotherapy Market, by Type, 2018 - 2033 (USD Million)
- Table 11 US Stereotactic Radiation Therapy Market, by Type, 2018 - 2033 (USD Million)
- Table 12 US Veterinary Oncology Market, by Cancer Type, 2018 - 2033 (USD Million)
- Table 13 Canada Veterinary Oncology market, by Animal Type, 2018 - 2033 (USD Million)
- Table 14 Canada Veterinary Oncology market, by Therapy, 2018 - 2033 (USD Million)
- Table 15 Canada Radiotherapy Market, by Type, 2018 - 2033 (USD Million)
- Table 16 Canada Stereotactic Radiation Therapy Market, by Type, 2018 - 2033 (USD Million)
- Table 17 Canada Veterinary Oncology Market, by Cancer Type, 2018 - 2033 (USD Million)
List of Figures
- Fig. 1 North America Veterinary Oncology market segmentation
- Fig. 2 Market research process
- Fig. 3 Information procurement
- Fig. 4 Primary research pattern
- Fig. 5 Data Analysis Models
- Fig. 6 Market Formulation And Validation
- Fig. 7 Data Validating & Publishing
- Fig. 8 Volume x Price Analysis
- Fig. 9 Commodity flow analysis
- Fig. 10 Market snapshot
- Fig. 11 Segment snapshot
- Fig. 12 Competitive landscape snapshot
- Fig. 13 Parent market outlook, 2022
- Fig. 14 Ancillary market outlook, 2022
- Fig. 15 North America Veterinary Oncology market: PESTEL analysis
- Fig. 16 Estimated Number of Veterinary Service Establishments in the U.S., 2018 to 2030
- Fig. 17 North America Veterinary Oncology market by Animal Type: Key takeaways
- Fig. 18 North America Veterinary Oncology market by Animal Type, Market share, 2022 & 2033
- Fig. 19 Canine market, 2018 - 2033 (USD Million)
- Fig. 20 Feline market, 2018 - 2033 (USD Million)
- Fig. 21 Equine market, 2018 - 2033 (USD Million)
- Fig. 22 North America Veterinary Oncology market by Therapy: Key takeaways
- Fig. 23 North America Veterinary Oncology market by Therapy, market share, 2022 & 2033
- Fig. 24 Radiotherapy market, 2018 - 2033 (USD Million)
- Fig. 25 Stereotactic Radiation Therapy market, 2018 - 2033 (USD Million)
- Fig. 26 LINAC market, 2018 - 2033 (USD Million)
- Fig. 27 Others market, 2018 - 2033 (USD Million)
- Fig. 28 Conventional Radiation Therapy market, 2018 - 2033 (USD Million)
- Fig. 29 Surgery market, 2018 - 2033 (USD Million)
- Fig. 30 Chemotherapy market, 2018 - 2033 (USD Million)
- Fig. 31 Immunotherapy market, 2018 - 2033 (USD Million)
- Fig. 32 Other Therapies market, 2018 - 2033 (USD Million)
- Fig. 33 North America Veterinary Oncology market by Cancer Type: Key takeaways
- Fig. 34 North America Veterinary Oncology market by Cancer Type, market share, 2022 & 2033
- Fig. 35 Skin Cancers market, 2018 - 2033 (USD Million)
- Fig. 36 Lymphomas market, 2018 - 2033 (USD Million)
- Fig. 37 Sarcomas market, 2018 - 2033 (USD Million)
- Fig. 38 Others market, 2018 - 2033 (USD Million)
- Fig. 39 Regional Marketplace: Key Takeaways
- Fig. 40 North America Veterinary Oncology market estimates and forecasts, 2018 - 2033 (USD Million)
- Fig. 41 U.S. Veterinary Oncology market estimates and forecasts, 2018 - 2033 (USD Million)
- Fig. 42 Canada Veterinary Oncology market estimates and forecasts, 2018 - 2033 (USD Million)
- Fig. 43 Market participant categorization
- Fig. 44 Heat map analysis
- Fig. 45 Key strategies deployed by market players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.